$BLUW News
Last published 5y ago
- 5y agoBLUWClarus Therapeutics Closes Transaction With Blue Water, Debuts as a Publicly Traded Company to Develop Androgen and Metabolic TherapiesGlobeNewswireBusiness combination with Blue Water Acquisition Corp., a special purpose acquisition company, completed on September 9, 2021 Combined company to be renamed Clarus Therapeutics Holdings, Inc. Clarus Therapeutics Holdings, Inc.'s common stock
- 5y agoBLUWBLUWUBLUWWBlue Water Acquisition Corp. Announces Stockholder Approval of Business Combination with Clarus Therapeutics, Inc.GlobeNewswireGREENWICH, Conn., Aug. 27, 2021 (GLOBE NEWSWIRE) -- Blue Water Acquisition Corp. (NASDAQ:BLUW), a special purpose acquisition company ("Blue Water"), today announced that its stockholders have voted to approve the proposed business combination (the "Bu
- 5y agoBLUWBLUWUBLUWWBlue Water Acquisition Corp. Announces Change of Special Meeting of Shareholders Date to August 27, 2021GlobeNewswireNEW YORK, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Blue Water Acquisition Corp. (NASDAQ: BLUW) ("Blue Water" or the "Company"), a special purpose acquisition company (SPAC) that previously announced a planned business combination with Clarus Therapeutics,
- 5y agoBLUWBlue Water Acquisition Corp. Announces Date for Special Meeting of Stockholders to Vote on Transaction With Clarus Therapeutics, Inc.PR NewswireGREENWICH, Conn., July 30, 2021 /PRNewswire/ -- Blue Water Acquisition Corp. (NASDAQ:BLUW) ("Blue Water"), a special purpose acquisition company ("SPAC") led by Joseph Hernandez, today announced that it has scheduled a special meeting of its stockholde
- 5y agoBLUWClarus Therapeutics And HavaH Therapeutics Announce Licensing Agreement For Product To Treat Androgen-Dependent Inflammatory Breast Disease And Certain Forms Of Breast CancerPR NewswireNORTHBROOK, Ill. and NORTH ADELAIDE, South Australia, May 25, 2021 /PRNewswire/ -- Clarus Therapeutics Inc. ("Clarus"), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men
- 5y agoBLUWHGVLEAFSEAHMoore Kuehn Encourages LEAF, SEAH, HGV, and BLUW Investors to Contact Law FirmPR NewswireNEW YORK, May 3, 2021 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to share
- 5y agoBLUWBlue Water Acquisition Corporation Announces Merger Agreement with Clarus Therapeutics, Forming A Publicly Listed Company To Address Unmet Needs Of Men And Women Through Development Of Androgen And Metabolic TherapiesPR NewswireNORTHBROOK, Ill. and GREENWICH, Conn., April 27, 2021 /PRNewswire/ -- Clarus Therapeutics Inc. ("Clarus"), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women,
- 5y agoBLUWBLUWUBLUWWBlue Water Acquisition Corp. Receives Expected Notice from Nasdaq Regarding Delayed Annual ReportGlobeNewswireNew York, NY, April 22, 2021 (GLOBE NEWSWIRE) -- Blue Water Acquisition Corp. (NASDAQ:BLUWU) (the "Company") announced today that it received a notice ("Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") stating t
- 5y agoBLUWBlue Water Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing February 9, 2021GlobeNewswireGreenwich, Conn., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Blue Water Acquisition Corp. (the “Company”) announced that, commencing February 9, 2021, holders of the units sold in the Company’s initial...